Search research articles
Contact Us
Filters
Showing results (51-60 of 58) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 58 results.
British Journal of Pharmacology
|
August 6, 2000
Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonist
C Routledge, S M Bromidge, S F Moss, et al.
Psychopharmacology
|
February 24, 2001
Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity
D N Jones, J Gartlon, F Parker, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Data-centric artificial intelligence and cancer research: construction of a real-world head and neck treatment data repository
V Butterworth, T Young, H Drake, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 2001
Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134)
S M Bromidge, S E Clarke, T Gager, et al.
Journal of Medicinal Chemistry
|
May 5, 2000
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the rat
G Stemp, T Ashmeade, C L Branch, et al.
Journal of Medicinal Chemistry
|
May 9, 1998
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo
L M Gaster, F E Blaney, S Davies, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 1999
Orexin A activates locus coeruleus cell firing and increases arousal in the rat
J J Hagan, R A Leslie, S Patel, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 17, 2000
Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A
C Reavill, S G Taylor, M D Wood, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 58) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 58 results.
British Journal of Pharmacology
|
August 6, 2000
Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonist
C Routledge, S M Bromidge, S F Moss, et al.
Psychopharmacology
|
February 24, 2001
Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity
D N Jones, J Gartlon, F Parker, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Data-centric artificial intelligence and cancer research: construction of a real-world head and neck treatment data repository
V Butterworth, T Young, H Drake, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 2001
Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134)
S M Bromidge, S E Clarke, T Gager, et al.
Journal of Medicinal Chemistry
|
May 5, 2000
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the rat
G Stemp, T Ashmeade, C L Branch, et al.
Journal of Medicinal Chemistry
|
May 9, 1998
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo
L M Gaster, F E Blaney, S Davies, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 15, 1999
Orexin A activates locus coeruleus cell firing and increases arousal in the rat
J J Hagan, R A Leslie, S Patel, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 17, 2000
Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A
C Reavill, S G Taylor, M D Wood, et al.
Page
of 6